Lineage Point Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$716K Sell
64,795
-205
-0.3% -$2.22K 0.15% 171
2026
Q1
$705K Hold
65,000
0.17% 137
2025
Q4
$695K Buy
+65,000
New +$693K 0.26% 81

Other funds holding GPAT

Lineage Point Capital's GPAT Position: Q2 2026 in Review

Lineage Point Capital reduced its GP-Act III Acquisition Corp (GPAT) stake by 0.32% in Q2 2026, selling an estimated $2.22K and leaving 64,795 shares worth $716K. The position accounts for 0.15% of the portfolio, ranked #171.

Lineage Point Capital first reported a position in GPAT in Q4 2025 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Lineage Point Capital held 64,795 shares of GP-Act III Acquisition Corp worth $716K as of Q2 2026.
  • Lineage Point Capital sold 205 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $2.22K.
  • GP-Act III Acquisition Corp made up 0.15% of Lineage Point Capital's portfolio in Q2 2026, its #171 holding.
  • Lineage Point Capital first reported a position in GP-Act III Acquisition Corp in Q4 2025 and has held it in 3 quarters since.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Lineage Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.